Segment Data (Tables)

3 Months Ended

Dec. 31, 2023

Segment Reporting [Abstract]

Revenue from External Customers by Geographic Area

Revenues by segment, organizational unit and geographical areas for the three-month periods are detailed below. The Company has no material intersegment revenues.

	Three Months Ended December 31,
(Millions of dollars)	2023						2022
	United States		International		Total		United States		International		Total
Medical
Medication Delivery Solutions	$	639	$	413	$	1,052	$	620	$	419	$	1,039
Medication Management Solutions	594		153		747		564		142		706
Pharmaceutical Systems	127		304		431		119		290		409
Total segment revenues	$	1,360	$	870	$	2,230	$	1,303	$	852	$	2,154
Life Sciences
Integrated Diagnostic Solutions	$	444	$	470	$	913	$	508	$	445	$	952
Biosciences	143		232		375		137		212		349
Total segment revenues	$	587	$	701	$	1,288	$	645	$	657	$	1,302
Interventional
Surgery	$	280	$	88	$	369	$	287	$	76	$	363
Peripheral Intervention	234		220		454		236		197		433
Urology and Critical Care	287		78		365		259		74		333
Total segment revenues	$	802	$	386	$	1,188	$	782	$	347	$	1,129
Total Company revenues	$	2,749	$	1,957	$	4,706	$	2,730	$	1,856	$	4,586

Financial Information for Company's Segments

Segment income for the three-month periods was as follows:

	Three Months Ended December 31,
(Millions of dollars)	2023		2022
Income Before Income Taxes
Medical	$	535	$	554
Life Sciences	372		433
Interventional	291		301
Total Segment Operating Income	1,198		1,288
Integration and restructuring expense	(75)		(44)
Net interest expense	(77)		(96)
Other unallocated items (a)	(688)		(667)
Total Income Before Income Taxes	$	359	$	481

(a)Primarily comprised of foreign exchange, certain general and administrative expenses and share-based compensation expense.